サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：呼吸器合胞体ウイルス診断薬の世界市場：産業分析、規模、シェア、成長、動向、予測（2023～2030年）
市場調査レポート
商品コード
1377881

呼吸器合胞体ウイルス診断薬の世界市場：産業分析、規模、シェア、成長、動向、予測（2023～2030年）

Global Respiratory Syncytial Virus Diagnostics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日: | 発行: Value Market Research | ページ情報: 英文 157 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
呼吸器合胞体ウイルス診断薬の世界市場：産業分析、規模、シェア、成長、動向、予測（2023～2030年）
出版日: 2023年09月01日
発行: Value Market Research
ページ情報: 英文 157 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の呼吸器合胞体ウイルス診断薬の市場規模は、2022年に9億9,820万米ドルとなり、2023～2030年にかけてCAGR 10.2%で成長し、2030年には21億7,105万米ドルに達すると予測されています。

呼吸器合胞体ウイルス診断薬は、呼吸器系を主に冒す一般的なウイルス病原体である呼吸器合胞体ウイルスを検出・同定するために使用される様々な検査や方法を指します。このウイルスは、乳幼児、幼児、高齢者における呼吸器感染症の主な原因であり、特に脆弱な集団において、軽い風邪のような症状から重症の呼吸器疾患まで、さまざまな症状を引き起こす可能性があります。RSVを正確かつタイムリーに診断することは、適切な患者管理と感染対策にとって極めて重要です。

市場力学

呼吸器合胞体ウイルス診断薬市場は、いくつかの重要な要因によって成長を遂げています。RSVは、特に乳幼児や高齢者、免疫力の低下した人に重篤な疾患を引き起こす可能性のある呼吸器系ウイルスとして流行しています。この流行は、季節的な流行と相まって、正確でタイムリーな診断の必要性を強調しています。PCRのような分子アッセイやポイント・オブ・ケア検査（POCT）を含む診断技術の進歩により、RSV検出の感度とスピードが向上し、診断がより効率的で利用しやすくなっています。迅速なPOCTが利用できるようになったことは、複雑な臨床検査への依存を減らし、臨床現場において特に有用です。特にヘルスケア専門家の間でRSVの影響に対する認識が高まり、特に小児医療や老人医療においてRSV検査がより考慮されるようになっています。公衆衛生の準備とサーベイランスも、アウトブレイクを追跡し対応するためにRSV診断に依存しています。さらに、世界人口の高齢化と旅行の世界化により、様々な地域で重症RSV感染のリスクが高まっており、診断薬に対する需要をさらに押し上げています。革新的な診断技術が開発され続け、RSVの深刻さに対する認識が高まるにつれ、RSV診断薬市場はさらに拡大し、この重大な呼吸器ウイルスの早期発見と介入が確実になると予想されます。

調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、呼吸器合胞体ウイルス診断薬の世界市場における各セグメントを包括的に評価することもできます。呼吸器合胞体ウイルス診断薬業界の成長と動向は、本調査に全体的なアプローチを提供します。

地域分析

このセクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにおける呼吸器合胞体ウイルス診断薬市場の現在と将来の需要を強調する地域展望をカバーしています。さらに、本レポートは、すべての主要地域における個々のアプリケーションセグメントの需要、推定・予測に焦点を当てています。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 呼吸器合胞体ウイルス診断薬 - 産業分析

  • イントロダクション - 市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 呼吸器合胞体ウイルス診断薬の世界市場分析：製品別

  • 製品別概要
  • 実績データと予測データ
  • 製品別分析
  • Direct Fluorescent Antibody (Dfa) Method
  • Rapid Antigen Diagnostic Test (Radt)
  • Molecular Diagnostics
  • Chromatographic Immunoassay (Gravity Driven　Test, Oligo Chromatography (Oc))
  • Diagnostic Imaging
  • Gel Microdroplets
  • Flow Cytometry
  • その他

第6章 呼吸器合胞体ウイルス診断薬の世界市場分析：最終用途別

  • 最終用途別概要
  • 実績データと予測データ
  • 最終用途別分析
  • 病院
  • 研究所
  • 診療所
  • 在宅医療

第7章 呼吸器合胞体ウイルス診断薬の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東・アフリカ

第8章 呼吸器合胞体ウイルス診断薬企業の競合情勢

  • 呼吸器合胞体ウイルス診断薬市場競争
  • パートナーシップ/提携/合意
  • 合併・買収
  • 新製品発売
  • その他の開発

第9章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Becton
  • Dickinson and Company
  • Novartis AG
  • Abbott
  • Ortho Clinical Diagnostics
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche Ltd.
  • BIOMERIEUX
  • DiaSorin SpA
  • Merck KGaA
  • Quidel Corp.
  • Coris BioConcept
  • Siemens Healthcare SA
  • Quest Diagnostics Inc.
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Product (USD MN)
  • Direct Fluorescent Antibody (Dfa) Method Market Sales by Geography (USD MN)
  • Rapid Antigen Diagnostic Test (Radt) Market Sales by Geography (USD MN)
  • Molecular Diagnostics Market Sales by Geography (USD MN)
  • Chromatographic Immunoassay (Gravity Driven Test, Oligo Chromatography (Oc)) Market Sales by Geography (USD MN)
  • Diagnostic Imaging Market Sales by Geography (USD MN)
  • Gel Microdroplets Market Sales by Geography (USD MN)
  • Flow Cytometry Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis Market by End-Use (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Laboratory Market Sales by Geography (USD MN)
  • Clinics Market Sales by Geography (USD MN)
  • Homecare Market Sales by Geography (USD MN)
  • Global Respiratory Syncytial Virus Diagnostics Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Respiratory Syncytial Virus Diagnostics Report
  • Market Research Process
  • Market Research Methodology
  • Global Respiratory Syncytial Virus Diagnostics Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by End-Use
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product (USD MN)
  • Direct Fluorescent Antibody (Dfa) Method Market Sales by Geography (USD MN)
  • Rapid Antigen Diagnostic Test (Radt) Market Sales by Geography (USD MN)
  • Molecular Diagnostics Market Sales by Geography (USD MN)
  • Chromatographic Immunoassay (Gravity Driven Test, Oligo Chromatography (Oc)) Market Sales by Geography (USD MN)
  • Diagnostic Imaging Market Sales by Geography (USD MN)
  • Gel Microdroplets Market Sales by Geography (USD MN)
  • Flow Cytometry Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by End-Use (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Laboratory Market Sales by Geography (USD MN)
  • Clinics Market Sales by Geography (USD MN)
  • Homecare Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR112112234

The global demand for Respiratory Syncytial Virus Diagnostics Market is presumed to reach the market size of nearly USD 2171.05 MN by 2030 from USD 998.2 MN in 2022 with a CAGR of 10.2% under the study period 2023 - 2030.

Respiratory syncytial virus (RSV) diagnostics refer to the various tests and methods used to detect and identify respiratory syncytial virus, a common viral pathogen that primarily affects the respiratory system. The virus is a major cause of respiratory tract infections in infants, young children, and older adults, and it can lead to conditions ranging from mild cold-like symptoms to severe respiratory illness, especially in vulnerable populations. Accurate and timely diagnosis of RSV is crucial for appropriate patient management and infection control.

MARKET DYNAMICS:

The Respiratory Syncytial Virus (RSV) diagnostics market is experiencing growth driven by several key factors. RSV is a prevalent respiratory virus that can cause severe illness, particularly in infants, the elderly, and individuals with weakened immune systems. This prevalence, coupled with seasonal outbreaks, underscores the need for accurate and timely diagnostics. Advancements in diagnostic technology, including molecular assays like PCR and point-of-care testing (POCT), have enhanced the sensitivity and speed of RSV detection, making diagnostics more efficient and accessible. The availability of rapid POCTs is particularly valuable in clinical settings, reducing the reliance on complex laboratory testing. Increased awareness of RSV's impact, especially among healthcare professionals, has contributed to greater consideration of RSV testing, particularly in pediatric and geriatric care. Public health preparedness and surveillance also rely on RSV diagnostics to track and respond to outbreaks. Additionally, the aging global population and the globalization of travel have raised the risk of severe RSV infections in various regions, further driving the demand for diagnostics. As innovative diagnostic technologies continue to develop and awareness of RSV's severity grows, the market for RSV diagnostics is expected to expand further, ensuring early identification and intervention for this significant respiratory virus.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of respiratory syncytial virus diagnostics. The growth and trends of respiratory syncytial virus diagnostics industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the respiratory syncytial virus diagnostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Direct Fluorescent Antibody (Dfa) Method
  • Rapid Antigen Diagnostic Test (Radt)
  • Molecular Diagnostics
  • Chromatographic Immunoassay (Gravity Driven Test, Oligo Chromatography (Oc))
  • Diagnostic Imaging
  • Gel Microdroplets
  • Flow Cytometry
  • Others

By End-Use

  • Hospitals
  • Laboratory
  • Clinics
  • Homecare

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Respiratory Syncytial Virus Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Respiratory Syncytial Virus Diagnostics market include Becton, Dickinson, and Company, Novartis AG, Abbott, Ortho Clinical Diagnostics, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., BIOMERIEUX, DiaSorin SpA, Merck KGaA, Quidel Corp., Coris BioConcept, Siemens Healthcare SA, Quest Diagnostics Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . RESPIRATORY SYNCYTIAL VIRUS DIAGNOSTICS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By End-Use
    • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL RESPIRATORY SYNCYTIAL VIRUS DIAGNOSTICS MARKET ANALYSIS BY PRODUCT

  • 5.1 Overview by Product
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Product
  • 5.4 Direct Fluorescent Antibody (Dfa) Method Historic and Forecast Sales by Regions
  • 5.5 Rapid Antigen Diagnostic Test (Radt) Historic and Forecast Sales by Regions
  • 5.6 Molecular Diagnostics Historic and Forecast Sales by Regions
  • 5.7 Chromatographic Immunoassay (Gravity Driven Test, Oligo Chromatography (Oc)) Historic and Forecast Sales by Regions
  • 5.8 Diagnostic Imaging Historic and Forecast Sales by Regions
  • 5.9 Gel Microdroplets Historic and Forecast Sales by Regions
  • 5.10. Flow Cytometry Historic and Forecast Sales by Regions
  • 5.11 Others Historic and Forecast Sales by Regions

6 . GLOBAL RESPIRATORY SYNCYTIAL VIRUS DIAGNOSTICS MARKET ANALYSIS BY END-USE

  • 6.1 Overview by End-Use
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by End-Use
  • 6.4 Hospitals Historic and Forecast Sales by Regions
  • 6.5 Laboratory Historic and Forecast Sales by Regions
  • 6.6 Clinics Historic and Forecast Sales by Regions
  • 6.7 Homecare Historic and Forecast Sales by Regions

7 . GLOBAL RESPIRATORY SYNCYTIAL VIRUS DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2. North America By Segment Sales Analysis
    • 7.3.3. North America By Country Sales Analysis
    • 7.3.4. United State Sales Analysis
    • 7.3.5. Canada Sales Analysis
    • 7.3.6. Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2. Europe by Segment Sales Analysis
    • 7.4.3. Europe by Country Sales Analysis
    • 7.4.4. United Kingdom Sales Analysis
    • 7.4.5. France Sales Analysis
    • 7.4.6. Germany Sales Analysis
    • 7.4.7. Italy Sales Analysis
    • 7.4.8. Russia Sales Analysis
    • 7.4.9. Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2. Asia Pacific by Segment Sales Analysis
    • 7.5.3. Asia Pacific by Country Sales Analysis
    • 7.5.4. China Sales Analysis
    • 7.5.5. India Sales Analysis
    • 7.5.6. Japan Sales Analysis
    • 7.5.7. South Korea Sales Analysis
    • 7.5.8. Australia Sales Analysis
    • 7.5.9. South East Asia Sales Analysis
    • 7.5.10. Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2. Latin America by Segment Sales Analysis
    • 7.6.3. Latin America by Country Sales Analysis
    • 7.6.4. Brazil Sales Analysis
    • 7.6.5. Argentina Sales Analysis
    • 7.6.6. Peru Sales Analysis
    • 7.6.7. Chile Sales Analysis
    • 7.6.8. Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2. Middle East & Africa by Segment Sales Analysis
    • 7.7.3. Middle East & Africa by Country Sales Analysis
    • 7.7.4. Saudi Arabia Sales Analysis
    • 7.7.5. UAE Sales Analysis
    • 7.7.6. Israel Sales Analysis
    • 7.7.7. South Africa Sales Analysis
    • 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE RESPIRATORY SYNCYTIAL VIRUS DIAGNOSTICS COMPANIES

  • 8.1. Respiratory Syncytial Virus Diagnostics Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9 . COMPANY PROFILES OF RESPIRATORY SYNCYTIAL VIRUS DIAGNOSTICS INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Becton
    • 9.3.1. Company Overview
    • 9.3.2. Company Revenue
    • 9.3.3. Products
    • 9.3.4. Recent Developments
  • 9.4. Dickinson and Company
    • 9.4.1. Company Overview
    • 9.4.2. Company Revenue
    • 9.4.3. Products
    • 9.4.4. Recent Developments
  • 9.5. Novartis AG
    • 9.5.1. Company Overview
    • 9.5.2. Company Revenue
    • 9.5.3. Products
    • 9.5.4. Recent Developments
  • 9.6. Abbott
    • 9.6.1. Company Overview
    • 9.6.2. Company Revenue
    • 9.6.3. Products
    • 9.6.4. Recent Developments
  • 9.7. Ortho Clinical Diagnostics
    • 9.7.1. Company Overview
    • 9.7.2. Company Revenue
    • 9.7.3. Products
    • 9.7.4. Recent Developments
  • 9.8. Thermo Fisher Scientific Inc.
    • 9.8.1. Company Overview
    • 9.8.2. Company Revenue
    • 9.8.3. Products
    • 9.8.4. Recent Developments
  • 9.9. Bio-Rad Laboratories Inc.
    • 9.9.1. Company Overview
    • 9.9.2. Company Revenue
    • 9.9.3. Products
    • 9.9.4. Recent Developments
  • 9.10. F. Hoffmann-La Roche Ltd.
    • 9.10.1. Company Overview
    • 9.10.2. Company Revenue
    • 9.10.3. Products
    • 9.10.4. Recent Developments
  • 9.11. BIOMERIEUX
    • 9.11.1. Company Overview
    • 9.11.2. Company Revenue
    • 9.11.3. Products
    • 9.11.4. Recent Developments
  • 9.12. DiaSorin SpA
    • 9.12.1. Company Overview
    • 9.12.2. Company Revenue
    • 9.12.3. Products
    • 9.12.4. Recent Developments
  • 9.13. Merck KGaA
    • 9.13.1. Company Overview
    • 9.13.2. Company Revenue
    • 9.13.3. Products
    • 9.13.4. Recent Developments
  • 9.14. Quidel Corp.
    • 9.14.1. Company Overview
    • 9.14.2. Company Revenue
    • 9.14.3. Products
    • 9.14.4. Recent Developments
  • 9.15. Coris BioConcept
    • 9.15.1. Company Overview
    • 9.15.2. Company Revenue
    • 9.15.3. Products
    • 9.15.4. Recent Developments
  • 9.16. Siemens Healthcare SA
    • 9.16.1. Company Overview
    • 9.16.2. Company Revenue
    • 9.16.3. Products
    • 9.16.4. Recent Developments
  • 9.17. Quest Diagnostics Inc.
    • 9.17.1. Company Overview
    • 9.17.2. Company Revenue
    • 9.17.3. Products
    • 9.17.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies